C-LEcta and ANKA have developed Acrylerase, a new food enzyme that reduces acrylamide in instant coffee and ready-to-drink coffee beverages. This patented technology is the first to target acrylamide directly, and offers significant benefits over existing mitigation measures.
As acrylamide is considered carcinogenic, the limitation and mitigation of this process contaminant in food is a priority in regulatory acts worldwide. Typically, acrylamide is formed when starchy food materials are exposed to high heat, such as during roasting and extraction to produce soluble coffee, coffee concentrates, as well as cereal- or chicory-based coffee surrogates.
Acrylerase is the first commercially available enzyme for direct decomposition of acrylamide, enabling effective on-site control of acrylamide levels during the processing of soluble coffee and coffee extracts. It is a flexible and simple drop-in solution that can be easily integrated into existing manufacturing processes. Thus, Acrylerase can help with regulatory compliance without the need for other costly mitigation measures. All this makes Acrylerase a game-changing application in the manufacturing of soluble coffee and coffee extracts. Dr Marc Struhalla, CEO of c-LEcta, expressed excitement in introducing Acrylerase to the market.
“This innovative enzyme product offers a practical solution for soluble coffee manufacturers. Acrylerase® can efficiently reduce acrylamide levels without compromising taste or disrupting production processes.”
Jan Schwital, Managing Director of ANKA, a coffee technology company, shared the same excitment.
“We believe simplicity and efficiency are key to any successful industrial application. Acrylerase provides just that for controlling acrylamide in instant coffee and coffee extracts.”
Consumers are becoming more and more aware of the potential risk of acrylamide in food. In some countries such as South Korea and in the EU, directives and regulations are already in force to mitigate acrylamide and limit consumer exposure, i.e., by introducing benchmark levels and monitoring acrylamide levels in various product categories, including soluble coffee. In addition, the introduction of fixed maximum limits is currently under discussion by the European Commission.
“Acrylerase not only offers soluble coffee manufacturers a much simpler and more flexible way to comply with acrylamide regulations than was previously possible, but also enables usage of coffee volumes that may otherwise be rejected due to high acrylamide formation”, said Oliver Süße-Herrmann, Managing Director of ANKA.
